Abbonarsi

A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease - 15/03/14

Doi : 10.1016/j.gie.2013.10.027 
Evan S. Dellon, MD, MPH 1, 2, , Hannah P. Kim, MD 1, Sarah L.W. Sperry, MD 1, David A. Rybnicek, MD 1, John T. Woosley, MD, PhD 3, Nicholas J. Shaheen, MD, MPH 1, 2
1 Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
2 Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 
3 Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA 

Reprint requests: Evan S. Dellon, MD, CB#7080, Bioinformatics Building, 130 Mason Farm Rd, UNC-CH, Chapel Hill, NC 27599-7080.

Abstract

Background

Phenotypes of eosinophilic esophagitis (EoE) are not well-characterized.

Objective

To describe clinical features of patients with EoE with predefined phenotypes, determine predictors of these phenotypes, and make inferences about the natural history of EoE.

Design

Retrospective study.

Setting

Tertiary-care center.

Patients

Incident EoE cases from 2001 to 2011 that met consensus diagnostic guidelines.

Intervention

Review of records.

Main Outcome Measurements

Endoscopic phenotypes, including fibrostenotic, inflammatory, or mixed. Other groups of clinical characteristics examined included atopy, level of esophageal eosinophilia, and age of symptom onset. Multinomial logistic regression assessed predictors of phenotype status.

Results

Of 379 cases of EoE identified, there were no significant phenotypic differences by atopic status or level of eosinophilia. Those with the inflammatory phenotype were more likely to be younger than those with mixed or fibrostenotic (13 vs 29 vs 39 years, respectively; P < .001) and less likely to have dysphagia, food impaction, and esophageal dilation (P < .001 for all). The mean symptom length before diagnosis was shorter for inflammatory (5 vs 8 vs 8 years; P = .02). After multivariate analysis, age and dysphagia independently predicted phenotype. The odds ratio (OR) for fibrostenosis for each 10-year increase in age was 2.1 (95% CI, 1.7-2.7). The OR for dysphagia was 7.0 (95% CI, 2.6-18.6).

Limitations

Retrospective, single-center study.

Conclusion

In this large EoE cohort, the likelihood of fibrostenotic disease increased markedly with age. For every 10-year increase in age, the odds of having a fibrostenotic EoE phenotype more than doubled. This association suggests that the natural history of EoE is a progression from an inflammatory to a fibrostenotic disease.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : EoE, eos/hpf


Mappa


 DISCLOSURE: This work was supported, in part, by National Institutes of Health Award K23 DK090073. No other financial relationships relevant to this publication were disclosed.
 If you would like to chat with an author of this article, you may contact Dr Dellon at edellon@med.unc.edu.
 See CME section: p. 663.


© 2014  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 79 - N° 4

P. 577 - aprile 2014 Ritorno al numero
Articolo precedente Articolo precedente
  • Revis(it)ing Barrett's esophagus
  • George Triadafilopoulos
| Articolo seguente Articolo seguente
  • Narrowing the focus on fibrostenotic eosinophilic esophagitis
  • Stephen M. Lagana, Julian A. Abrams

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.